波士顿科学44亿最新收购,强势押注热门赛道

医疗器械创新网
05 Mar

3月3日,波士顿科学公司(纽约证券交易所代码:BSX)宣布,已签订对私营医疗器械公司SoniVie Ltd.的最终收购协议。此次交易总价值达6亿美元(约合人民币44亿元)。此次收购将凭借用于治疗高血压的经肾动脉去交感神经疗法,扩充波士顿科学的心脏介入治疗产品组合。SoniVie 成立于 2015 年,总部位于美国明尼苏达州,专注于高血压管理的最小侵入式解决方案。其核心产品 TIVUS™血管内超声...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10